Welcome to our dedicated page for ORIQ news (Ticker: ORIQ), a resource for investors and traders seeking the latest updates and insights on ORIQ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ORIQ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ORIQ's position in the market.
Origin Investment Corp I (NASDAQ:ORIQU) has successfully completed its initial public offering (IPO) of 6,000,000 units at $10.00 per unit, raising a total of $60 million. Each unit consists of one ordinary share and one-half of one redeemable warrant.
The units began trading on the Nasdaq Global Market on July 2, 2025, under the symbol "ORIQU". Once separated, the ordinary shares and warrants will trade under "ORIQ" and "ORIQW" respectively. Each whole warrant allows the purchase of one ordinary share at $11.50. ThinkEquity served as the sole book-running manager, with a 45-day over-allotment option for an additional 900,000 units.
Origin Investment Corp I (NASDAQ:ORIQU) has announced the pricing of its $60 million initial public offering, consisting of 6,000,000 units priced at $10.00 per unit. Each unit includes one Class A ordinary share and one-half of one redeemable warrant.
The units will begin trading on the Nasdaq Global Market on July 2, 2025, under the symbol "ORIQU". Each whole warrant allows holders to purchase one Class A ordinary share at $11.50 per share. The warrants become exercisable 30 days after completing the initial business combination. The Company has granted underwriters a 45-day option to purchase up to 900,000 additional units to cover over-allotments.
ThinkEquity is serving as the sole book-running manager for this blank check company's IPO, which is expected to close on July 3, 2025.
